TNF and rheumatoid arthritis: Cytokine blockade is currently being evaluated for efficacy in other inflammatory diseases, for example through targeting of the pro-inflammatory mediators IL-17 and tumor necrosis factor α (TNFα) in rheumatoid arthritis [117].